| Director, Biostatistics | Gilead Sciences | United States | 2026-07-14 |
| Sr Director, Public Affairs, External Affairs | Gilead Sciences | United States | 2026-07-14 |
| Sr Director, DTP, HIV, Long-Acting Treatment | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Executive Director, Corporate Development | Gilead Sciences | Shanghai, China | 2026-07-14 |
| VP Global Patient Safety & Global Safety Therapeutic Area Head - Oncology | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Assoc Director, Biostatistics | Gilead Sciences | Parsippany, United States | 2026-07-14 |
| Sr. Director, US Contracting & Pricing Strategy | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Associate Director, Biostatistics | Gilead Sciences | United States | 2026-07-14 |
| Associate Director, PDM Strategy | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Director, Corporate Development | Gilead Sciences | Shanghai, China | 2026-07-14 |
| Director, Pathobiology | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Director, Biostatistics | Gilead Sciences | United States | 2026-07-14 |
| Director, Biostatistics | Gilead Sciences | United States | 2026-07-14 |
| Executive Director, Asset Team Leader- Inflammation | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Director, Epidemiology | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Director, PDM Strategy | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Sr Director, Analytical Development | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Associate Director, Patient Safety- Virology | Gilead Sciences | United States | 2026-07-14 |
| Director, Project Management- Inflammation | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Director, Market Access & Reimbursement- Oncology | Gilead Sciences | United States | 2026-07-14 |
| Vice President, Federal Government Affairs | Gilead Sciences | Washington, United States | 2026-07-14 |
| Director, HCP NPP Promo, Long-Acting Treatment | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Director, DTP Promo, Long Acting Treatment | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Associate Director, DTP Promo, Long-Acting Treatment | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Sr Director, Biostatistics | Gilead Sciences | United States | 2026-07-14 |
| Director, Biostatistics | Gilead Sciences | United States | 2026-07-14 |
| Director, Market Access -- Trade Strategy | Gilead Sciences | United States | 2026-07-14 |
| Senior Director, Opinion Leader Programming HIV Treatment | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Associate Director, Ominchannel Experience Technology Product Lead | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Associate Director, Program Process & Portfolio Technology Product Lead | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Associate Director, International Technology Product Lead | Gilead Sciences | Singapore, Singapore | 2026-07-14 |
| Director, Biostatistics - Virology - Foster City, CA or Parsippany, NJ | Gilead Sciences | United States | 2026-07-14 |
| Associate Director, HIV Prevention Community Engagement & Advocacy, U.S. Public Affairs | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Sr Director, Federal Drug Pricing Policy | Gilead Sciences | United States | 2026-07-14 |
| Associate Director, Patient Safety | Gilead Sciences | Cambridge, United Kingdom | 2026-07-14 |
| Sr Business Unit Director Cell Therapies - Canada | Gilead Sciences | Mississauga, Canada | 2026-07-14 |
| Director - RA Resource, Analytics and Insights Lead | Gilead Sciences | Cambridge, United Kingdom | 2026-07-14 |
| Director, Corporate Storytelling and Editorial Strategy | Gilead Sciences | Foster City, United States | 2026-07-14 |
| Director, Enterprise EH&S | Bio-Techne | Minneapolis, United States | 2026-07-14 |
| Global Director of BSS Downstream Filtration | Repligen | United States | 2026-07-14 |
| Director Continuous Improvement | Repligen | Marlborough, United States | 2026-07-14 |
| Sr. Director, Fluid Management | Repligen | Waltham, United States | 2026-07-14 |
| Associate Director, Digital Workplace | Repligen | Waltham, United States | 2026-07-14 |
| Executive Director, DMPK | Neurocrine Biosciences | San Diego, United States | 2026-07-14 |
| Director, HEOR | Neurocrine Biosciences | San Diego, United States | 2026-07-14 |
| Associate Director Biometrics Standards & Integrations | Neurocrine Biosciences | San Diego, United States | 2026-07-14 |
| VP, Intellectual Property โ Biologics | Neurocrine Biosciences | United States | 2026-07-14 |
| Sr. Scientific Director, Toxicology | Neurocrine Biosciences | San Diego, United States | 2026-07-14 |
| Assoc. Scientific Director, Pharmacometrics | Neurocrine Biosciences | San Diego, United States | 2026-07-14 |
| Associate Scientific Director, HEOR | Neurocrine Biosciences | San Diego, United States | 2026-07-14 |